Mather Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,767
| Closed | -$379K | – | 726 |
|
|
2025
Q1 | $379K | Buy |
2,767
+1,039
| +60% | +$142K | ﹤0.01% | 433 |
|
|
2024
Q4 | $264K | Buy |
1,728
+1,428
| +476% | +$218K | ﹤0.01% | 492 |
|
|
2024
Q3 | $58.2K | Sell |
300
-923
| -75% | -$179K | ﹤0.01% | 852 |
|
|
2024
Q2 | $264K | Buy |
1,223
+181
| +17% | +$39K | ﹤0.01% | 559 |
|
|
2024
Q1 | $270K | Sell |
1,042
-6
| -0.6% | -$1.55K | ﹤0.01% | 461 |
|
|
2023
Q4 | $271K | Sell |
1,048
-115
| -10% | -$29.8K | ﹤0.01% | 470 |
|
|
2023
Q3 | $299K | Sell |
1,163
-474
| -29% | -$122K | 0.01% | 438 |
|
|
2023
Q2 | $466K | Buy |
+1,637
| New | +$466K | 0.01% | 361 |
|
|
2021
Q4 | – | Sell |
-721
| Closed | -$204K | – | 391 |
|
|
2021
Q3 | $204K | Buy |
721
+68
| +10% | +$19.2K | ﹤0.01% | 275 |
|
|
2021
Q2 | $226K | Sell |
653
-82
| -11% | -$28.4K | 0.01% | 258 |
|
|
2021
Q1 | $206K | Buy |
+735
| New | +$206K | 0.01% | 255 |
|
|
2020
Q4 | – | Sell |
-963
| Closed | -$273K | – | 253 |
|
|
2020
Q3 | $273K | Sell |
963
-433
| -31% | -$123K | 0.01% | 193 |
|
|
2020
Q2 | $373K | Buy |
+1,396
| New | +$373K | 0.02% | 156 |
|